These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 25800544)

  • 1. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
    Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
    Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
    Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA
    Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
    Zanghi G; Vaughan AM
    Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Flannery EL; Kangwanrangsan N; Chuenchob V; Roobsoong W; Fishbaugher M; Zhou K; Billman ZP; Martinson T; Olsen TM; Schäfer C; Campo B; Murphy SC; Mikolajczak SA; Kappe SHI; Sattabongkot J
    Mol Ther Methods Clin Dev; 2022 Sep; 26():427-440. PubMed ID: 36092359
    [No Abstract]   [Full Text] [Related]  

  • 6. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
    Roth A; Maher SP; Conway AJ; Ubalee R; Chaumeau V; Andolina C; Kaba SA; Vantaux A; Bakowski MA; Thomson-Luque R; Adapa SR; Singh N; Barnes SJ; Cooper CA; Rouillier M; McNamara CW; Mikolajczak SA; Sather N; Witkowski B; Campo B; Kappe SHI; Lanar DE; Nosten F; Davidson S; Jiang RHY; Kyle DE; Adams JH
    Nat Commun; 2018 May; 9(1):1837. PubMed ID: 29743474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
    Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
    White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
    Elife; 2014 Nov; 3():. PubMed ID: 25406065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses.
    Schäfer C; Dambrauskas N; Reynolds LM; Trakhimets O; Raappana A; Flannery EL; Roobsoong W; Sattabongkot J; Mikolajczak SA; Kappe SHI; Sather DN
    Cell Host Microbe; 2021 May; 29(5):752-756.e4. PubMed ID: 33857426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
    Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
    Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imported tertian malaria resistant to primaquine.
    Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
    Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of
    Gualdrón-López M; Flannery EL; Kangwanrangsan N; Chuenchob V; Fernandez-Orth D; Segui-Barber J; Royo F; Falcón-Pérez JM; Fernandez-Becerra C; Lacerda MVG; Kappe SHI; Sattabongkot J; Gonzalez JR; Mikolajczak SA; Del Portillo HA
    Front Microbiol; 2018; 9():1271. PubMed ID: 29988527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
    Hatipoğlu M; Ulçay A; Turhan V; Karagöz E; Erdem H; Acar A; Oncül O; Görenek L
    Turkiye Parazitol Derg; 2014 Jun; 38(2):120-3. PubMed ID: 25016120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.
    Pewkliang Y; Rungin S; Lerdpanyangam K; Duangmanee A; Kanjanasirirat P; Suthivanich P; Sa-Ngiamsuntorn K; Borwornpinyo S; Sattabongkot J; Patrapuvich R; Hongeng S
    Malar J; 2018 Jan; 17(1):50. PubMed ID: 29370800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Kristensen KL; Dragsted UB
    Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological concepts in recurrent Plasmodium vivax malaria.
    Markus MB
    Parasitology; 2018 Nov; 145(13):1765-1771. PubMed ID: 29564998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
    Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
    J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters.
    Popovici J; Tebben K; Witkowski B; Serre D
    Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():36-42. PubMed ID: 33529838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium vivax liver stage assay platforms using Indian clinical isolates.
    Subramani PA; Vartak-Sharma N; Sreekumar S; Mathur P; Nayer B; Dakhore S; Basavanna SK; Kalappa DM; Krishnamurthy RV; Mukhi B; Mishra P; Yoshida N; Ghosh SK; Shandil R; Narayanan S; Campo B; Hasegawa K; Anvikar AR; Valecha N; Sundaramurthy V
    Malar J; 2020 Jun; 19(1):214. PubMed ID: 32571333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.